Easton Pharmaceuticals, Inc. (EAPH)

[wjb007]

EAPH/AMFE: By EASTON PARM; Easton Pharmaceuticals is pleased to announce that its investment in AMFIL Technologies, made in 2014 is performing well and will provide Easton with a substantial return on investment. Amfil have recently finalized and acquired a revenue generating acquisition that is projecting over $10 Million in revenue with many other positive updates to follow, which includes its grozone technology for use in medical marijuana facilities. Additional updates on AMFIL are expected shortly. EAPH calls AMFE their PARTNER.